Could Bisphenol-A Have a Role in the Etiology of Neural Tube Defects

NCT05454085 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2022-07-12

No results posted yet for this study

Summary

Our aim in this study is in patients with a diagnosis of neural tube defect; is the measurement of BPA levels in maternal blood and amniotic fluid.

Conditions

  • Neural Tube Defects
  • Bisphenol-A

Interventions

DIETARY_SUPPLEMENT

Bisphenol-A

measurement of BPA levels in maternal blood and amniotic fluid

Sponsors & Collaborators

  • Bursa Yuksek Ihtisas Education and Research Hospital

    collaborator UNKNOWN
  • Sanliurfa Mehmet Akif Inan Education and Research Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-15
Primary Completion
2022-04-15
Completion
2022-04-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05454085 on ClinicalTrials.gov